Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-01-06 4:06 pm Purchase | 13D | Aevi Genomic Medicine LLC GNMX | Children's Hospital of Philadelphia Foundation | 57,280,927 49.1% | 6,473,450 (+12.74%) | View |
| 2019-12-06 5:18 pm Purchase | 13D | Aevi Genomic Medicine LLC GNMX | Children's Hospital of Philadelphia Foundation | 50,807,477 52.3% | 4,661,074 (+10.10%) | View |
| 2019-11-20 4:30 pm Purchase | 13D | Aevi Genomic Medicine LLC GNMX | Children's Hospital of Philadelphia Foundation | 46,146,403 47.5% | 24,834,817 (+116.53%) | View |
| 2019-10-29 11:16 am Sale | 13D | Spark Therapeutics Inc. ONCE | Children's Hospital of Philadelphia Foundation | 1,629,932 4.2% | -362,228 (-18.18%) | View |
| 2019-10-22 4:59 pm Unchanged | 13D | Aevi Genomic Medicine LLC GNMX | Children's Hospital of Philadelphia Foundation | 21,311,586 31.5% | 0 (Unchanged) | View |
| 2019-03-29 5:27 pm Purchase | 13D | Aevi Genomic Medicine LLC GNMX | Children's Hospital of Philadelphia Foundation | 21,311,586 31.5% | 63,333 (+0.30%) | View |
| 2019-03-07 10:06 am Sale | 13D | Spark Therapeutics Inc. ONCE | Children's Hospital of Philadelphia Foundation | 1,992,160 5.2% | -1,990,699 (-49.98%) | View |